Jason Gerlach, Principal & Managing Director, Sunrise Capital Partners LLC says that traditional diversification strategies no longer work b...
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Chris Verbacher, CEO, Sanofi says that the firm has been built so that it could grow without having to rely on research and development into...
Ahead of the Facebook IPO, the company wants to make privacy policies clear and simple, reports CNBC's Julia Boorstin. Scott Sandell of NEA,...
Cramer shares six stocks to watch, and reveals them in under 60 seconds.
CNBC's Seema Mody reports on the latest details of the FDA advisory panel's review of Arena Pharmaceuticals' anti-obesity drug.
The FMHR traders share their top trades of the hour. Jonathan Chaplin, Credit Suisse analyst, explains why his firm upgraded AT&T and Verizo...
CNBC's Brian Shactman reports JP Morgan shares are down almost 7% in after-hours trading; Yahoo's CEO says he didn't provide the company wit...
Arena Pharmaceuticals' new anti-obesity drug will be reviewed by a panel of FDA advisers on Friday, with CNBC's Seema Mody.
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
